UPWARD MOVERS:
Adams Respiratory Therapeutics (Nasdaq: ARXT) +$5.20; Entered into a settlement agreement with Mutual Pharmaceutical Co. and United Research Laboratories, Inc., both wholly owned subsidiaries of Pharmaceutical Holdings
Chattem (Nasdaq: CHTT) +$4.60; Reports Q1 earnings of $0.71 per share, above the consensus of $0.61. Revenues came in at $100.8 million versus the consensus of $101 million. Sees FY07 EPS of $2.71-$2.96 versus prior guidance of of $2.66-$2.91 and the consensus of $2.76.
IHS (NYSE: IHS) +$4.14; Reports Q1 adj-EPS of $0.38, 3 cents better than estimates.(0.35) Revenues were $152.6 million vs. $147.96 million consensus. IHS revises guidance upwards to revenue growth in the range of 11 to 13 percent and adjusted EBITDA growth in the range of 18 to 22 percent for the full year ending November 30, 2007.
Marathon Oil Corp. (NYSE: MRO) +$3.66; Stock seeing interest on higher than normal volume. No specific news releases attributed to today’s move.
Orient-Express Hotels Ltd. (NYSE: OEH) +$3.07; Stock up on rumors the company may be the target of a takeover with a buyout price of $3 billion.
DOWNWARD MOVERS:
Scholastic Corp (NASDAQ: SCHL) -$4.97; Reports a Q3 loss of $0.18 (including $0.04 gain on the sale of an investment) vs. consensus for a loss of $0.08. Revenues were $497.0 million vs. $498.56 million consensus. Based on lower than expected results in Continuities in the third quarter, and the revised outlook for this business in the fourth quarter, the Company now expects full year earnings in the range of $1.40 to $1.60 per diluted share on revenues of $2.1 to $2.2 billion. (Current FY07 EPS consensus is $1.74 and revenue consensus is $2.19 billion)
Herman Miller (Nasdaq: MLHR) -$4.36; Reports Q3 EPS of $0.50, 2 cents worse than estimates.(0.52) Revenues were $484.8 million vs. $491.41 million consensus. Sees Q4 EPS of $0.47-$0.51, versus the consensus of $0.52. Sees Q4 revenues of $485-$505 million versus the consensus of $491.4 million.
CRA International (Nasdaq: CRAI) -$3.51; Reports Q1 earnings of $0.56 per share, 1 cent worse than estimates. Revenues came in at $83.3 million versus the consensus of $86.2 million.
CLARCOR (NYSE: CLC) -$3.31; Reports Q1 EPS of $0.32, 4 cents worse than estimates.(0.36) Revenues were $209.5 million vs. $222.04 million consensus. Reaffirms FY forecast.
Deere & Co. (NYSE: DE) -$2.77; UBS downgrades Deere from Buy to Neutral.
Top Gaining Stocks
Top Losing Stocks